U.S. Banks Stock News

On 2 June 2026, WEX Inc. presented at the Baird Global Consumer, Technology & Services Conference in New York, with Chief Financial Officer Jagtar Narula outlining the company’s current positioning. An interesting angle for investors is management’s emphasis on AI-driven automation and an approximately US$50 million 2026 cost-saving program alongside growth across Mobility, Benefits and Corporate Payments. Now, we’ll consider how WEX’s AI-focused efficiency drive may influence its existing...

Setting the scene for Nu Holdings Nu Holdings (NYSE:NU) has drawn fresh attention as investors reassess the digital bank’s share performance, with the stock down about 10% over the past month and roughly 12% over the past 3 months. See our latest analysis for Nu Holdings. While the 1 day share price return declined 1.07% to US$12.99 and the 30 day return is down 10.04%, the 1 year total shareholder return of 8.25% and 3 year total shareholder return of about 9x suggest longer term investors...

Encompass Health Corp. recently announced plans to build a freestanding, 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia, replacing its former 19-bed unit at WVU Medicine United Hospital Center and adding advanced therapy, dialysis and rehabilitation facilities. The temporary capacity expansion at Encompass Health Rehabilitation Hospital of Morgantown highlights how the company is prioritizing uninterrupted patient access while it upgrades and enlarges its regional...

In late May 2026, Dimensional Fund Advisors announced it had engaged SS&C Global Investor & Distribution Solutions to support ETF share-class launches and conversions for its U.S. multi-class funds, while Royal London Asset Management extended its partnership with SS&C to administer a new range of Australian feeder funds with about A$1,000 million in AUM. These expanded mandates underscore SS&C’s role as a core infrastructure provider for complex fund operations, spanning ETF share-class...

In late May 2026, Fiserv announced a partnership with Cognition to deploy Devin, an autonomous AI software engineer, to speed up modernization of its core banking platforms and enhance delivery of new capabilities to financial institution clients, while Experian revealed a separate collaboration using Fiserv’s VerifyNow Advantage to power real-time debit card verification for Experian Link. Together with fresh activist pressure from Jana Partners and a shareholder vote rejecting an...

Recent performance snapshot Corebridge Financial (CRBG) has seen its stock pull back recently, with the share price down 1.6% over the past day, 4.2% over the past week, and about 3.5% over the past month. Even with these shorter term declines, the stock is up roughly 5.9% over the past 3 months, while year to date it is down about 12.5% and the 1 year total return has fallen around 15.8%. See our latest analysis for Corebridge Financial. Overall, Corebridge Financial’s recent pullback...

Capital Clean Energy Carriers (CCEC) has drawn fresh attention after securing a 10 year time charter with Energy Trading Group for an LNG carrier and authorizing a 20 million share buyback program. See our latest analysis for Capital Clean Energy Carriers. At a share price of $23.10, CCEC has a 30 day share price return of 12.11% and a year to date share price return of 13.18%. Its 5 year total shareholder return of 118.79% points to stronger long term compounding than the 2.85% 1 year total...

The United States market has shown a robust performance, climbing 1.6% in the last week and an impressive 28% over the past year, with earnings projected to grow by 17% annually. In this dynamic environment, identifying stocks that are potentially undervalued can be crucial for investors looking to capitalize on growth opportunities, especially when there is notable insider action signaling confidence in these companies' prospects.

Over the last 7 days, the United States market has risen 1.6%, and in the past year, it has climbed 28%, with earnings anticipated to grow by 17% per annum over the next few years. In such a dynamic environment, identifying high growth tech stocks that align with these positive trends can be crucial for investors looking to capitalize on potential opportunities in this sector.

Over the last 7 days, the United States market has risen 1.6%, contributing to a 28% increase over the past year, with earnings anticipated to grow by 17% annually in the coming years. In this context of robust market performance, identifying stocks that are trading below their intrinsic value can offer investors potential opportunities for growth and value appreciation.

The United States market has experienced a notable upswing, climbing 1.6% in the last week and up 28% over the past year, with earnings projected to grow by 17% annually. In this environment, growth companies with high insider ownership stand out as potentially attractive investments due to their alignment of interests between management and shareholders and their potential for significant earnings expansion.

The United States market has shown positive momentum recently, climbing 1.6% over the past week and 28% over the last year, with expectations of continued earnings growth. While the term "penny stock" may evoke images of speculative trading from a bygone era, these stocks can still present valuable opportunities when backed by strong financials and potential for growth. This article explores several penny stocks that stand out for their financial resilience and potential to offer investors...

The United States market has shown robust performance with a 1.6% increase over the last week and a remarkable 28% rise over the past year, alongside forecasts of 17% annual earnings growth. In this thriving environment, dividend stocks with yields starting at 3.2% can offer investors an attractive opportunity for income generation while participating in the market's upward momentum.

In early June 2026, APA Corporation filed a shelf registration to potentially issue 24,160,000 common shares, totaling about US$880.15 million, in an ESOP-related offering, while it had previously affirmed a regular quarterly dividend of US$0.25 per share payable on August 21, 2026. The combination of a sizable employee stock ownership plan funding mechanism and a maintained cash dividend highlights APA’s focus on balancing capital formation with ongoing shareholder cash returns. We will now...

Nextpower overview and recent performance Nextpower (NXT) has drawn fresh attention as investors reassess solar and energy technology stocks following recent trading swings, with the share price closing at US$145.02 and showing mixed short term returns. See our latest analysis for Nextpower. While the share price fell 7.28% over the last day, it still has a 56.31% year to date share price return and a very large 1 year total shareholder return, which suggests that momentum has remained strong...

DraftKings Inc. recently expanded Chief Financial Officer Alan Ellingson’s responsibilities to include principal accounting officer, while continuing Erik Bradbury as Chief Accounting Officer, and presented at the ISG AI Impact Summit in Boston as part of broader AI-focused activity in Massachusetts. At the same time, analysts have highlighted DraftKings as a leader in the emerging prediction market space, aligning its sports-betting roots with new technology and AI initiatives in the...

Pfizer reported new seven-year data from the Phase 3 CROWN trial at ASCO 2026, highlighting LORBRENA for untreated ALK-positive advanced non small cell lung cancer. The company also presented Phase 3 BREAKWATER results in metastatic colorectal cancer using a BRAFTOVI based combination. In metastatic prostate cancer, TALZENNA plus XTANDI showed a 52% reduction in the risk of progression or death versus standard care. For investors tracking NYSE:PFE, these oncology updates arrive with the...

Tempus AI (TEM) has highlighted a series of product announcements, including FDA clearance for tumor-only use of its xT CDx platform and new AI driven diagnostics that are drawing fresh investor attention. See our latest analysis for Tempus AI. These product updates and regulatory milestones have arrived alongside a volatile trading pattern, with a 1-day share price return of 4.62% and 7-day share price return of 14.34%. The year-to-date share price return is down 15.33%, and the 1-year total...

In late May and early June 2026, BioNTech SE presented new clinical data at the ASCO Annual Meeting in Chicago, highlighting encouraging anti-tumor activity from its late-stage oncology candidates pumitamig and gotistobart in multiple Phase 2 and pivotal trial settings. The breadth of BioNTech’s oncology program, spanning more than 25 Phase 2 and Phase 3 trials, including 13 pivotal studies and several novel-novel combinations, underscores its effort to evolve into a diversified...

Keysight Technologies stock performance snapshot Keysight Technologies (KEYS) has been drawing attention after recent trading saw the stock close at US$330. The move comes alongside mixed short term returns and longer term performance metrics that investors are reassessing. See our latest analysis for Keysight Technologies. Recent share price moves tell a mixed story, with the stock down over the past week and month, but supported by a stronger 90 day share price return and a very strong 1...

Wondering whether Markel Group's current share price still reflects its long term potential, or if the recent pullback has created a mispriced opportunity. The stock closed at US$1,789.67, with the share price down 3.7% over the past week, slightly higher by 0.6% over the past month, and lower by 16.0% year to date, while still showing gains of 33.4% over three years and 47.9% over five years. These mixed returns have put valuation back in focus for many investors, especially given the...

Evaluating whether Merck at around US$115 per share still offers value, or whether most of the opportunity is already priced in, starts with understanding what the current market price actually reflects. The stock has pulled back about 5.9% over the past week, but is still up 2.7% over the last 30 days, 8.2% year to date, and 56.5% over the past year. This naturally raises questions about how much risk and upside are now incorporated into the price. Recent coverage has focused on Merck's...

Wondering if Walt Disney at around US$102.85 is a bargain, fairly priced, or still carrying a premium after years of ups and downs. The stock is roughly flat over the last week and month, while the year to date return is down 8.0% and the 1 year return is down 7.9%, set against a 3 year gain of 15.7% and a 5 year return that is down 40.5%. Recent moves sit against a backdrop of ongoing interest in Disney's streaming, parks, and content businesses. This keeps the stock in focus whenever...

In recent days, Centene Corporation was highlighted by Zacks as a top growth pick, carrying a Zacks Rank #1 after its consensus earnings estimate for the current year increased 15.3% over the last 60 days. This recognition, alongside a PEG ratio of 0.46 versus the industry’s 1.03 and a Growth Score of A, underlines how analysts currently view Centene’s earnings profile as comparatively attractively valued for its growth characteristics. We’ll now explore how this earnings estimate upgrade...